The mean of analysts' price targets for Dyne Therapeutics (DYN) points to a 285.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

After reaching an important support level, Medpace Holdings, Inc. (MEDP) could be a good stock pick from a technical perspective. MEDP recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

The mean of analysts' price targets for Zevra Therapeutics (ZVRA) points to an 117.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 142.7% upside potential for uniQure (QURE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The consensus price target hints at a 29.4% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

LOS ANGELES , July 31, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Replimune Group, Inc. ("Replimune" or "the Company") (NASDAQ: REPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 22, 2024 and July 21, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before September 22, 2025.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

InterDigital (IDCC) came out with quarterly earnings of $6.52 per share, beating the Zacks Consensus Estimate of $3.36 per share. This compares to earnings of $4.57 per share a year ago.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

BABX offers 2x daily exposure to Alibaba via swaps, suitable only for short-term trading due to daily reset and compounding effects. Holding BABX beyond a single day can result in value decay and significant divergence from intended returns, especially in volatile markets. Liquidity is a concern with BABX's relatively low AUM; however, trading volumes can provide adequate depth.

Albemarle Corporation (NYSE:ALB ) Q2 2025 Earnings Conference Call July 31, 2025 8:00 AM ET Company Participants Jerry Kent Masters - Chairman, President & CEO Meredith H. Bandy - Vice President of Investor Relations & Sustainability Neal R.

Shell PLC (LSE:SHEL, NYSE:SHEL) shares rose on Thursday after the oil major delivered second-quarter results that topped expectations, with investors giving a guarded welcome to another robust update. UBS kept its 'buy' rating and a 2,950p price target, highlighting an 8% earnings beat at the EBITDA level and a 14% beat at the net income line, driven by stronger performance in the upstream and marketing businesses and tighter cost controls.

LOS ANGELES , July 31, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sable Offshore Corp. ("Sable" or "the Company") (NYSE: SOC) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's May 21, 2025 secondary public offering (the "SPO") and/or between May 19, 2025 and June 3, 2025, both dates inclusive (the "Class Period"), are encouraged to contact the firm before September 26, 2025.

Avino has recently made a series of new acreage acquisitions that promise to accelerate production increases in the short and medium term. The possibility that the company can reduce the percentage of copper it extracts from 31% to 9% in order to increase the values of silver from 49% to 67%. In 2022, the company completed the acquisition of La Preciosa. Avino paid a total of $15.3 million in cash and $14 million in stocks.

Robinhood Markets Inc (NASDAQ:HOOD) stock is up 1.5% to trade at $107.68 at last glance, after the electronic trading platform beat top- and bottom-line expectations for the second quarter.

NEW ORLEANS, July 31, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 23, 2025 to file lead plaintiff applications in a securities class action lawsuit against Flywire Corporation (“Flywire” or the “Company”) (NasdaqGS: FLYW), if they purchased the Company's securities between February 28, 2024 and February 25, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.